1235
     RDKit          3D

 14 14  0  0  1  0  0  0  0  0999 V2000
   -4.4329    4.7935    3.6331 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7085   -2.6652    2.1772 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5341    3.4944    6.0343 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.2333   -1.7613    0.1845 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2931   -1.4086    0.0433 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5521    0.4464    1.2415 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1303   -1.0546    1.2146 C   0  0  1  0  0  0  0  0  0  0  0  0
   -4.3642    1.2556    2.5157 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3590    2.6706    2.4574 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3983    0.6430    3.7760 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4048    3.4249    3.6352 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4434   -1.8645    1.1223 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4388    1.4037    4.9458 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4530    2.7859    4.8696 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  2 12  1  0
  3 14  1  0
  4 12  2  0
  6  8  1  0
  7 12  1  0
  7  6  1  0
  7  5  1  6
  8  9  2  0
  8 10  1  0
  9 11  1  0
 10 13  2  0
 11 14  2  0
 13 14  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB01235

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
APRD00309; EXPT01107

>  <COMMON_NAME>  (1) 
Levodopa

>  <CAS_NUMBER>  (1) 
59-92-7

>  <UNII>  (1) 
46627O600J

>  <SYNONYMS>  (1) 
(−)-3-(3,4-dihydroxyphenyl)-L-alanine; (−)-dopa; 3-Hydroxy-L-tyrosine; 3,4-Dihydroxy-L-phenylalanine; Dihydroxy-L-phenylalanine; L-3,4-dihydroxyphenylalanine; L-beta-(3,4-Dihydroxyphenyl)alanine; L-DOPA; Levodopa; Levodopum; β-(3,4-dihydroxyphenyl)-L-alanine; β-(3,4-dihydroxyphenyl)alanine

$$$$
